U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects - PowerPoint PPT Presentation

1 / 6
About This Presentation
Title:

U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects

Description:

U.S. Emerging Lung Cancer Therapeutics ... Oncology Imclone Systems, Inc. Immunex Corp. Immunogen, Inc. Inex Pharmaceuticals Isis Ivax Corp. Millennium ... – PowerPoint PPT presentation

Number of Views:60
Avg rating:3.0/5.0
Slides: 7
Provided by: JanetC160
Category:

less

Transcript and Presenter's Notes

Title: U.S. Emerging Lung Cancer Therapeutics Markets Novel Targeted Therapies Lower Side Effects


1
U.S. Emerging Lung Cancer Therapeutics
MarketsNovel Targeted Therapies Lower Side
Effects
  • "Standard doses of chemotherapy may prove to be
    life threatening in the vast majority of lung
    cancer patients. Novel targeted therapeutics in
    combination with chemotherapy are expected to
    make lung cancer more manageable and extend the
    life of patients in stages three and four of the
    disease."

Pharmaceuticals Analyst Team Frost Sullivan
2
Key Features
  • Detailed insights into recent developments and
    trends
  • Drivers, restraints, challenges, and strategic
    recommendations
  • Analytical insights into current topics and
    emerging
  • applications in the lung cancer therapeutics
    market
  • Market-sizing and competitive analysis
  • Market forecasts and opportunity analyses
  • Quarterly assessments
  • End-user analysis

3
What We Offer
  • Coverage The United States
  • Proven methodology using extensive primary and
    secondary data as well as research
  • Focused information and strategies that cover
    business and technology issues
  • Credible data and analyses that highlight
    industry dynamics
  • Precise strategies to help you create winning
    business plans

4
Who Will Benefit?
  • Current Market Participants
  • Find out where you stand in comparison with the
    competitors
  • Assess current and future drivers as well as
    restraints
  • Determine and exploit new market share
    opportunities
  • New Entrants
  • Analyze the associated challenges
  • Calculate timescales for strategy implementation
  • Position yourself to capitalize on the unmet
    needs of the market
  • Investment Community
  • Analyze long-term strategies of companies
  • Determine which participants will outperform the
    competition
  • Assess the attractiveness of investing in the
    market

5
Key Market Participants
Abgenix Aeterna Laboratories, Inc. Allos
Therapeutics Aronex Astra-Zeneca
Pharmaceuticals Aventis Bristol-Myers
Squibb Celgene, Inc. Cell Pathways Eli
Lilly Entremed, Inc. Gaenera Corp. Glaxo-Smithklin
e Hoffmann La Roche IBC Pharmaceuticals,
Inc. Ilex Oncology
Imclone Systems, Inc. Immunex Corp. Immunogen,
Inc. Inex Pharmaceuticals Isis Ivax
Corp. Millennium Pharmaceuticals Novelos
Therapeutics OSI Pharma Pharmacia Corp. Ribozyme
Pharmaceuticals Sonus Pharmaceuticals Supergen,
Inc. Titan Pharma Zarix, Inc.
6
For More Information
  • Call toll free 877 GO FROST
  • (877.463.7876)
  • Fax toll free 888.690.3329
  • E-mail myfrost_at_frost.com
  • Visit www.frost.com
Write a Comment
User Comments (0)
About PowerShow.com